Circulation (New York, N.Y.), 2016-11, Vol.134 (21), p.e468-e495
2016
Details
- Autor(en) / Beteiligte
- Titel
- Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association
- Ist Teil von
- Circulation (New York, N.Y.), 2016-11, Vol.134 (21), p.e468-e495
- Ort / Verlag
- United States: by the American College of Cardiology Foundation and the American Heart Association, Inc
- Erscheinungsjahr
- 2016
- Link zum Volltext
- Quelle
- EZB-FREE-00999 freely available EZB journals
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0009-7322eISSN: 1524-4539DOI: 10.1161/CIR.0000000000000456Titel-ID: cdi_proquest_miscellaneous_1835446949
- Format
- –
- Schlagworte
- American Heart Association, Cardiovascular Diseases - diagnosis, Cardiovascular Diseases - drug therapy, Cardiovascular Diseases - epidemiology, Clinical Decision-Making, Comorbidity, Consensus, Drug Interactions, Dyslipidemias - diagnosis, Dyslipidemias - drug therapy, Dyslipidemias - epidemiology, Evidence-Based Medicine, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics, Polypharmacy, Risk Assessment, Risk Factors, Treatment Outcome, United States